Insiders who reported open-market trades in the last 12 months at the companies Jerome Benedict Durso files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Gregory L. Weaver - $49K in ALT purchases and sales in the last 12 months
John Gill - $31K in ALT purchases and sales in the last 12 months
Wayne Pisano - $20K in ALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jerome Benedict Durso is a corporate insider, tracked as President and CEO, Director of Altimmune, Inc. (ALT). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jerome Benedict Durso submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jerome Benedict Durso been buying or selling stock?
Recorded transactions: 3 open-market purchases ($162K) and 0 open-market sales across all tracked filings.
Jerome Benedict Durso is President and CEO, Director of Altimmune, Inc. (ALT). 5 SEC Form 4 filings on record going back to 2025, most recently on 13 August 2026. Most recent open-market trade: bought $44K of ALT on 13 August 2026. Lifetime open-market purchases: $162K.
Recent transactions
3
The latest 3 SEC Form 4 transactions reported by Jerome Benedict Durso.
InsiderAlpha's records for Jerome Benedict Durso go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. The typical open-market purchase is $54K (3 buys totaling $162K). The largest single buy on record is $71K of ALT in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
